CSIMarket Company Name, Ticker, Suppliers, else..


Janux Therapeutics Inc   (NASDAQ: JANX)
Other Ticker:  
 

Janux Therapeutics Inc

JANX's Fundamental analysis



Janux Therapeutics Inc 's sales fell in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 2829

Major Pharmaceutical Preparations industry recorded growth of revenues by 4.44 %

Janux Therapeutics Inc net loss increased from $-15 millions, to $-24 millions in first quarter of 2025,

• More on JANX's Growth


Janux Therapeutics Inc
realized a net loss in trailing twelve months.

Janux Therapeutics Inc realized cash reduction of $ -2.25 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 178.7.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.47.


• More on JANX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 16.39

Janux Therapeutics Inc
realized net loss in trailing twelve months.

Janux Therapeutics Inc realized cash outflow of $ -2.25per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 178.7.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.47.

Janux Therapeutics Inc Price to Book Ratio is at 1.65 lower than Industry Avg. of 34.99. and higher than S&P 500 Avg. of 0.01

• More on JANX's Valuation

•  Market Capitalization (Millions $) 1,668
•  Shares Outstanding (Millions) 62
•  Employees 37
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -78
•  Cash Flow (TTM) (Millions $) -139
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 16.39

•  Market Capitalization (Millions $) 1,668
•  Shares Outstanding (Millions) 62
•  Employees 37
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -78
•  Cash Flow (TTM) (Millions $) -139
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 58.47
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.04
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com